Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025International Journal of Scientific Research

In Vitro Susceptibility Comparison of Aztreonam Along With Ceftazidime-Avibactam Synergy Testing Methods and Aztreonamavibactam Against Carbapenem Resistant Organisms in Isolates Obtained From Cancer Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

PKPrajakta KulkarniGSGaurav SalunkeJSJyoti Sinol

Discussion

Loading...

Member takes

Overview

Observational analysis shows aztreonam-avibactam synergy in 79% of carbapenem-resistant isolates, indicating effective treatment.

Key Points

  • Aztreonam-avibactam showed 79% susceptibility against NDM-producing pathogens.
  • The broth disc elution method was effective for synergy testing in clinical isolates.
  • Ceftazidime-avibactam combined with aztreonam demonstrated the highest susceptibility rates.
  • Aztreonam-avibactam represents a viable treatment option against multidrug-resistant infections.

Cite This Study

Kulkarni et al. (2025) studied this question.

synapsesocial.com/papers/68c23d3ab210217d6478c884https://doi.org/10.36106/ijsr/3513169
View Full Paper
Ask AI
Bookmark
Share